FIELD: medicine, more particularly contrast agents for MP tomography, and also method of preparation and use thereof. SUBSTANCE: contrast agents have metal oxide, preferably supermagnetic iron oxide nucleus provided that it is thinly coated with electrolytic and synthetic polymers, especially polyamino acids. Invention makes it possible to prepare low-toxic agent which produces reduced or no effect on parameters of cardiovascular system, exhaustion of thrombocyte link, activation of complement and blood coagulation. EFFECT: low-toxic contrast agent. 16 cl, 36 ex, 6 dwg, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| BIODEGRADABLE NONCOUPLED POLYMERS | 1993 |
|
RU2114865C1 |
| UTILIZATION OF PHYSIOLOGICALLY ACCEPTABLE CORPUSCULAR FERROMAGNETIC OR FERROMAGNETIC MATERIAL, METHOD OF MAGNETOMETRIC IMAGING, CHANGE-REVEALING PROCESS, UTILIZATION OF PHYSIOLOGICALLY ACCEPTABLE PARAMAGNETIC, SUPERPARAMAGNETIC, FERROMAGNETIC OR FERROMAGNETIC PARTICLES, AND IMAGING DEVICE | 1992 |
|
RU2137501C1 |
| METHOD FOR EXAMINING HUMAN OR ANIMAL BODY BY APPLYING MAGNETOMETRIC METHODS AND METHOD FOR DETECTING CHANGES IN HUMAN OR ANIMAL MAGNETIC SUSCEPTIBILITY | 1991 |
|
RU2102082C1 |
| METHOD FOR PREPARATION OF BETULIN FOR USE AS ADJUVANT IN VACCINE AGAINST SARS-COV-2 CORONAVIRUS | 2020 |
|
RU2749193C1 |
| NANOSTRUCTURED COMPOSITIONS FOR DELIVERY OF SILIBININ AND OTHER ACTIVE INGREDIENTS FOR TREATING EYE DISEASES | 2015 |
|
RU2726193C2 |
| CONTRASTING SUBSTANCE, METHOD OF ITS PREPARING, METHOD OF HUMAN OR ANIMAL BODY IMAGE PRODUCING | 1994 |
|
RU2128520C1 |
| SUSPENSION OF NANODIAMOND AGGREGATES AND SINGLE-NANO-SIZED NANODIAMOND DISPERSION | 2015 |
|
RU2700528C2 |
| METHOD OF PRODUCING A POLYMER-CONTAINING SILYBIN COMPOSITION | 2019 |
|
RU2716706C1 |
| CONTRAST AGENTS AND THEIR USING | 1993 |
|
RU2122432C1 |
| METHOD FOR PRODUCING ZETA-NEGATIVE NANODIAMOND DISPERSION AND ZETA-NEGATIVE NANODIAMOND DISPERSION | 2014 |
|
RU2681615C2 |
